Where can I verify the source and access all details for “Piramal Pharma Sellersville Manufacturing Facility FDA Inspection”?

This Taiyo project page references Whalesbook along with the original URL (https://www.whalesbook.com/corporate-news/English/other/Piramal-Pharmas-US-Plant-Gets-3-FDA-Voluntary-Action-Observations/6a00b82c707d23e8442007b6). Taiyo standardizes official data into a consistent, searchable project profile.

Piramal Pharma Sellersville Manufacturing Facility FDA Inspection

Q: What is the latest status of the project “Piramal Pharma Sellersville Manufacturing Facility FDA Inspection”?

The status recorded for “Piramal Pharma Sellersville Manufacturing Facility FDA Inspection” is under regulatory review.

One of 10,000+ projects Taiyo tracks in United States.

Source: Whalesbook

Project

Under Regulatory Review

Piramal Pharma Ltd.'s manufacturing facility in Sellersville, USA, underwent a US FDA inspection from May 4 to May 8, 2026. The inspection resulted in three Voluntary Action Indicated (VAI) observations, with no data integrity concerns. The company is preparing a detailed response to the FDA to address these observations and maintain compliance.

Status: Prospective
Sector: Manufacturing (Industrial)
Location: Sellersville, United States of America
Updated: 22 Jul 2026
Source: Whalesbook

ConstructChat

Ask ConstructChat about Piramal Pharma Sellersville Manufacturing Facility FDA Inspection

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information

3 Q

The project “Piramal Pharma Sellersville Manufacturing Facility FDA Inspection” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in Sellersville, United States. Taiyo aggregates data on it from Whalesbook.

Participants

Not available for this record.

Status

Original status	under regulatory review
Taiyo status	Prospective
Taiyo last update	2026-07-22

Contact

Not available for this record.

Description

Description	Piramal Pharma Ltd.'s manufacturing facility in Sellersville, USA, underwent a US FDA inspection from May 4 to May 8, 2026. The inspection resulted in three Voluntary Action Indicated (VAI) observations, with no data integrity concerns. The company is preparing a detailed response to the FDA to address these observations and maintain compliance.
Original sector	Pharmaceutical Manufacturing

Location

Country	United States of America (USA)
City	Sellersville

Source

Source	Whalesbook
URL

More Details

Record type	Project
Sector	Manufacturing (Industrial)
Article published date	2026-05-13

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

Every detail on this project
News and media coverage
Technical research

View all details

Free account · no card · lands you back on this project

Piramal Pharma Sellersville Manufacturing Facility FDA Inspection

Ask ConstructChat about Piramal Pharma Sellersville Manufacturing Facility FDA Inspection

Project Information FAQ

Project Information

Research

View all details

More Manufacturing (Industrial) projects in United States